The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

被引:2053
作者
Choe, H
Farzan, M
Sun, Y
Sullivan, N
Rollins, B
Ponath, PD
Wu, LJ
Mackay, CR
LaRosa, G
Newman, W
Gerard, N
Gerard, C
Sodroski, J
机构
[1] HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,BOSTON,MA 02115
[2] LEUKOSITE INC,CAMBRIDGE,MA 02142
[3] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT MED,BOSTON,MA 02115
[4] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,PERLMUTTER LAB,DEPT PEDIAT,DEPT MED,CHILDRENS HOSP,BOSTON,MA 02115
关键词
D O I
10.1016/S0092-8674(00)81313-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined the ability of chemokine receptors and related G protein-coupled receptors to facilitate infection by primary, clinical HIV-1 isolates. CCR5, when expressed along with CD4, the HIV-1 receptor, allowed cell lines resistant to most primary HIV-1 isolates to be infected. CCR3 facilitated infection by a more restricted subset of primary viruses, and binding of the CCR3 ligand, eotaxin, inhibited infection by these isolates. Utilization of CCR3 and CCR5 on the target cell depended upon the sequence of the third variable (V3) region of the HIV-1 gp120 exterior envelope glycoprotein. The ability of various members of the chemokine receptor family to support the early stages of HIV-1 infection helps to explain viral tropism and beta-chemokine inhibition of primary HIV-1 isolates.
引用
收藏
页码:1135 / 1148
页数:14
相关论文
共 108 条
  • [1] GENETIC-VARIABILITY OF THE AIDS VIRUS - NUCLEOTIDE-SEQUENCE ANALYSIS OF 2 ISOLATES FROM AFRICAN PATIENTS
    ALIZON, M
    WAINHOBSON, S
    MONTAGNIER, L
    SONIGO, P
    [J]. CELL, 1986, 46 (01) : 63 - 74
  • [2] HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEIN CD4-MEDIATED FUSION OF NONPRIMATE CELLS WITH HUMAN-CELLS
    ASHORN, PA
    BERGER, EA
    MOSS, B
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (05) : 2149 - 2156
  • [3] ASJO B, 1986, LANCET, V2, P660
  • [4] BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
  • [5] BARAK LS, 1994, J BIOL CHEM, V269, P2790
  • [6] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
    BARRESINOUSSI, F
    CHERMANN, JC
    REY, F
    NUGEYRE, MT
    CHAMARET, S
    GRUEST, J
    DAUGUET, C
    AXLERBLIN, C
    VEZINETBRUN, F
    ROUZIOUX, C
    ROZENBAUM, W
    MONTAGNIER, L
    [J]. SCIENCE, 1983, 220 (4599) : 868 - 871
  • [7] TARGET CELL-SPECIFIC DETERMINANTS OF MEMBRANE-FUSION WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 3RD-VARIABLE REGION AND GP41 AMINO TERMINUS
    BERGERON, L
    SULLIVAN, N
    SODROSKI, J
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (04) : 2389 - 2397
  • [8] EPSTEIN-BARR VIRUS-INDUCED GENES - 1ST LYMPHOCYTE-SPECIFIC G-PROTEIN-COUPLED PEPTIDE RECEPTORS
    BIRKENBACH, M
    JOSEFSEN, K
    YALAMANCHILI, R
    LENOIR, G
    KIEFF, E
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (04) : 2209 - 2220
  • [9] CRYPTIC NATURE OF ENVELOPE V3 REGION EPITOPES PROTECTS PRIMARY MONOCYTOTROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM ANTIBODY NEUTRALIZATION
    BOUHABIB, DC
    RODERIQUEZ, G
    ORAVECZ, T
    BERMAN, PW
    LUSSO, P
    NORCROSS, MA
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6006 - 6013
  • [10] DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENTRY IN THE CDR2 LOOP OF THE CD4 GLYCOPROTEIN
    BRAND, D
    SRINIVASAN, K
    SODROSKI, J
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (01) : 166 - 171